🚨 INJ JUST GOT A BIGGER SHOT AT THE U.S. ETF MARKET
Injective now has three U.S. ETF applications tied to INJ: 21Shares, Canary Capital, and REX-Osprey.
The latest development came from Injective CEO Eric Chen, who said he expects an INJ ETF could launch before 2027. The applications are still subject to the SEC process, so this is not an ETF approval.
Meanwhile, Injective has been expanding INJ beyond its own ecosystem. INJ went live natively on Solana through Sunrise, with Raydium and StonkFun among the launch partners.
Injective is also pushing tokenized assets through Stockdrop, combining INJ burns with tokenized-stock rewards.
So the real INJ story right now is:
ETF applications + Solana expansion + tokenized-asset infrastructure.
The ETF part is still pending — and that distinction matters.
$INJ .
.
.
#Injective #Crypto #Write2Earn Not financial advice. DYOR.